Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Liver Transplantation

  Free Subscription


07.04.2020

2 Am J Gastroenterol
2 Ann Surg
2 Clin Res Hepatol Gastroenterol
1 Clin Transplant
1 Dig Dis Sci
1 Hepatology
1 J Pediatr
4 PLoS One
1 Transpl Int
16 Transplant Proc
11 Transplantation


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. SALIM TI, Nestlerode LC, Lucatorto EL, Wasserman TL, et al
    Frailty as Tested by Gait Speed Is a Risk Factor for Liver Transplant Respiratory Complications.
    Am J Gastroenterol. 2020 Mar 31. doi: 10.14309/ajg.0000000000000609.
    PubMed         Abstract available

  2. AHAMED R, Philips CA, Augustine P
    Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis-A Beautiful but Incomplete Story.
    Am J Gastroenterol. 2019 Jun 12. doi: 10.14309/ajg.0000000000000294.
    PubMed        


    Ann Surg

  3. SOUBRANE O, Eguchi S, Uemoto S, Kwon CHD, et al
    Minimally Invasive Donor Hepatectomy for Adult Living Donor Liver Transplantation: An International, Multi-Institutional Evaluation of Safety, Efficacy and Early Outcomes.
    Ann Surg. 2020 Mar 27. doi: 10.1097/SLA.0000000000003852.
    PubMed         Abstract available

  4. JUNG KW, Song JG, Hwang GS
    Response to the Comment on "Effect of Remote Ischemic Preconditioning Conducted in Living Liver Donors on Postoperative Liver Function in Donors and Recipients Following Liver Transplantation: A Randomized Clinical Trial".
    Ann Surg. 2020 Mar 27. doi: 10.1097/SLA.0000000000003865.
    PubMed        


    Clin Res Hepatol Gastroenterol

  5. SCHIELKE A, Scatton O, Boelle PY, Perdigao F, et al
    Ischemic-type biliary lesions: A leading indication of liver retransplantation with excellent results.
    Clin Res Hepatol Gastroenterol. 2019;43:131-139.
    PubMed         Abstract available

  6. JU W, Li C, Zhang C, Ko DS, et al
    Outcome of the use of paediatric donor livers in adult recipients: A single Chinese centre experience.
    Clin Res Hepatol Gastroenterol. 2019;43:148-154.
    PubMed         Abstract available


    Clin Transplant

  7. FERRETTI F, Fraquelli M, Cantu P, Penagini R, et al
    Efficacy and safety of device-assisted enteroscopy ERCP in liver transplantation: a systematic review and meta-analysis.
    Clin Transplant. 2020 Mar 31:e13864. doi: 10.1111/ctr.13864.
    PubMed         Abstract available


    Dig Dis Sci

  8. ZORI A, Villanueva F, Hatamleh D, Ismael M, et al
    Favorable Survival with Non-curative Treatments for Patients with Early-Stage Hepatocellular Carcinoma After Liver Transplant Denial.
    Dig Dis Sci. 2020 Mar 26. pii: 10.1007/s10620-020-06201.
    PubMed         Abstract available


    Hepatology

  9. QIN J, Wang H, Qin X, Zhang P, et al
    Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient.
    Hepatology. 2020 Mar 27. doi: 10.1002/hep.31257.
    PubMed         Abstract available


    J Pediatr

  10. HARPAVAT S
    MMP-7: The Next Best Serum Biomarker for Biliary Atresia?
    J Pediatr. 2019 Mar 8. pii: S0022-3476(19)30112.
    PubMed        


    PLoS One

  11. SHONAKA T, Matsuno N, Obara H, Yoshikawa R, et al
    Impact of human-derived hemoglobin based oxygen vesicles as a machine perfusion solution for liver donation after cardiac death in a pig model.
    PLoS One. 2019;14:e0226183.
    PubMed         Abstract available

  12. STEGGERDA JA, Bloom MB, Noureddin M, Brennan TV, et al
    Higher thresholds for the utilization of steatotic allografts in liver transplantation: Analysis from a U.S. national database.
    PLoS One. 2020;15:e0230995.
    PubMed         Abstract available

  13. BRAL M, Pawlick R, Marfil-Garza B, Dadheech N, et al
    Pan-caspase inhibitor F573 mitigates liver ischemia reperfusion injury in a murine model.
    PLoS One. 2019;14:e0224567.
    PubMed         Abstract available

  14. BAJAJ JS, Fan S, Thacker LR, Fagan A, et al
    Serum and urinary metabolomics and outcomes in cirrhosis.
    PLoS One. 2019;14:e0223061.
    PubMed         Abstract available


    Transpl Int

  15. MINNEE RC, Darwish Murad S, Polak WG, Metselaar HJ, et al
    Combined liver-kidney transplantation; two for the price of one?
    Transpl Int. 2019 Apr 8. doi: 10.1111/tri.13438.
    PubMed         Abstract available


    Transplant Proc

  16. SILVA N, Coelho J, Marques H, Martins A, et al
    Case Report: Portal Vein Thrombosis, Surgical Alternatives in Liver Transplantation.
    Transplant Proc. 2020 Mar 26. pii: S0041-1345(20)30290.
    PubMed         Abstract available

  17. TOLEDO E, Castanedo S, Tolaretxipi EG, Lozano A, et al
    Validation of the Balance of Risk as a Predictor of Liver Transplant Survival in a Spanish Population.
    Transplant Proc. 2020 Mar 26. pii: S0041-1345(20)30253.
    PubMed         Abstract available

  18. FEIJO MS, Galdino-Vasconcelos MR, Simoes V, Atik F, et al
    Impact of Donor Positive Blood Culture in Deceased Donor Liver Transplantation.
    Transplant Proc. 2020 Mar 23. pii: S0041-1345(20)30096.
    PubMed         Abstract available

  19. RIAL X, Lopez-Monclus J, Lucena JL, Chaparro MD, et al
    Hepatic Epithelioid Hemangioendothelioma as a Rare Indication for Liver Transplantation.
    Transplant Proc. 2020 Mar 30. pii: S0041-1345(19)31831.
    PubMed         Abstract available

  20. CIECIURA T, Urbanowicz A, Foroncewicz B, Hryniewiecka E, et al
    Hepatocellular Carcinoma Is a Negative Predictor of Sustained Viral Response in Liver Transplant Recipients With Hepatitis C Treated With Direct-Acting Antivirals.
    Transplant Proc. 2020 Mar 30. pii: S0041-1345(19)31659.
    PubMed         Abstract available

  21. CIECIURA T, Hryniewiecka E, Foroncewicz B, Strzelczyk Z, et al
    Long-Term Follow-up of Liver Transplant Recipients Treated With Direct-Acting Antiviral Agents for Hepatitis C Recurrence After Transplantation.
    Transplant Proc. 2020 Mar 30. pii: S0041-1345(19)31656.
    PubMed         Abstract available

  22. TEJEDOR-TEJADA J, Alonso-Martin C, Almohalla-Alvarez C, Valenzuela EF, et al
    Immunosuppressive Treatment With mTOR Inhibitors for Malignancies After Liver Transplantation: Long-Term Survival Retrospective Analysis.
    Transplant Proc. 2020 Mar 22. pii: S0041-1345(20)30246.
    PubMed         Abstract available

  23. NACIF LS, de Cassia Gomes C, Paranagua-Vezozzo D, Flores Cassenote AJ, et al
    Liver Elastography in Acute Cellular Rejection After Liver Transplantation.
    Transplant Proc. 2020 Mar 23. pii: S0041-1345(20)30075.
    PubMed         Abstract available

  24. PERILLI V, Aceto P, Luca E, Sacco T, et al
    Further Hemodynamic Insight Into Patients Undergoing Liver Transplantation: A Preliminary Report on Cardiac Power Index.
    Transplant Proc. 2020 Mar 23. pii: S0041-1345(20)30126.
    PubMed         Abstract available

  25. PAGANO D, Barbara M, Seidita A, Cintorino D, et al
    Impact of Extended-Criteria Donor Liver Grafts on Benchmark Metrics of Clinical Outcome After Liver Transplantation: A Single Center Experience.
    Transplant Proc. 2020 Mar 25. pii: S0041-1345(20)30133.
    PubMed         Abstract available

  26. NACIF LS, Zanini LY, Waisberg DR, Costa Dos Santos JP, et al
    Adult-to-Adult Living Donor Liver Transplant: Hemodynamic Evaluation, Prognosis, and Recipient Selection.
    Transplant Proc. 2020 Mar 25. pii: S0041-1345(20)30299.
    PubMed         Abstract available

  27. GASTACA M, Gomez J, Terreros I, Izquierdo J, et al
    Endovascular Therapy of Arterial Complications Within the First Week After Liver Transplant.
    Transplant Proc. 2020 Mar 24. pii: S0041-1345(19)31543.
    PubMed         Abstract available

  28. GASTACA M, Prieto M, Palomares I, Bustamante J, et al
    Long-Term Outcomes of Liver Transplantation in Patients With Pretransplant Renal Dysfunction Treated With Induction Therapy and Delayed Reduced De Novo Once-Daily Tacrolimus.
    Transplant Proc. 2020 Mar 23. pii: S0041-1345(19)31600.
    PubMed         Abstract available

  29. KRASNODEBSKI M, Grat M, Morawski M, Wierzchowski M, et al
    Hepatic Epithelioid Hemangioendothelioma: A Rare Disease With Favorable Outcomes After Liver Transplantation.
    Transplant Proc. 2020 Mar 23. pii: S0041-1345(20)30121.
    PubMed         Abstract available

  30. TORTOLERO L, Nuno J, Buenadicha A, Gajate L, et al
    Protective Role of the Portocaval Shunt in Liver Transplantation.
    Transplant Proc. 2020 Mar 23. pii: S0041-1345(19)31803.
    PubMed         Abstract available

  31. NACIF LS, Zanini LY, Costa Dos Santos JP, Pereira JM, et al
    Intraoperative Temporary Portocaval Shunt in Liver Transplant.
    Transplant Proc. 2020 Mar 25. pii: S0041-1345(20)30301.
    PubMed         Abstract available


    Transplantation

  32. SAPISOCHIN G, Javle M, Lerut J, Ohtsuka M, et al
    Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular-cholangiocarcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
    Transplantation. 2020 Mar 23. doi: 10.1097/TP.0000000000003212.
    PubMed         Abstract available

  33. MEHTA N, Bhangui P, Yao FY, Mazzaferro V, et al
    Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
    Transplantation. 2020 Mar 23. doi: 10.1097/TP.0000000000003174.
    PubMed        

  34. HIBI T, Rela M, Eason J, Line PD, et al
    Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
    Transplantation. 2020 Mar 23. doi: 10.1097/TP.0000000000003118.
    PubMed         Abstract available

  35. BERENGUER M, Burra P, Ghobrial M, Hibi T, et al
    Posttransplant management of recipients undergoing liver transplantation for hepatocellular carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
    Transplantation. 2020 Mar 23. doi: 10.1097/TP.0000000000003196.
    PubMed         Abstract available

  36. RIZZARI MD, Safwan M, Sobolic M, Kitajima T, et al
    The Impact of Portal Vein Thrombosis on Liver Transplant Outcomes: Does Grade or Flow Rate Matter?
    Transplantation. 2020 Mar 18. doi: 10.1097/TP.0000000000003235.
    PubMed         Abstract available

  37. HOUBEN P, Dohler B, Weiss KH, Mieth M, et al
    Differential Influence of Donor Age Depending on the Indication for Liver Transplantation-A Collaborative Transplant Study Report.
    Transplantation. 2020;104:779-787.
    PubMed         Abstract available

  38. RHU J, Kim JM, Choi GS, Kwon CHD, et al
    The Authors' Reply: Anatomical and Extra-Anatomical Hepatic Artery Reconstruction During Living Donor Liver Transplantation: Is It Reasonable to Classify This Way?
    Transplantation. 2020;104:e112-e113.
    PubMed        

  39. CAILES B, Koshy AN, Gow P, Weinberg L, et al
    Inducible Left Ventricular Outflow Tract Obstruction in Patients Undergoing Liver Transplantation: Prevalence, Predictors and Association With Cardiovascular Events.
    Transplantation. 2020 Mar 27. doi: 10.1097/TP.0000000000003245.
    PubMed         Abstract available

  40. KADOHISA M, Inomata Y, Uto K, Hayashida S, et al
    Impact of Donor Age on the Outcome of Living-donor Liver Transplantation: Special Consideration to the Feasibility of Using Elderly Donors.
    Transplantation. 2020 Mar 30. doi: 10.1097/TP.0000000000003246.
    PubMed         Abstract available

  41. SADD CJ, Osman F, Li Z, Chybowski A, et al
    Long-term Outcomes and Survival in Moderate-Severe Portopulmonary Hypertension After Liver Transplant.
    Transplantation. 2020 Mar 30. doi: 10.1097/TP.0000000000003248.
    PubMed         Abstract available

  42. LOGRE E, Bert F, Khoy-Ear L, Janny S, et al
    Risk Factors and Impact of Perioperative Prophylaxis on the Risk of Extended-spectrum beta-Lactamase-producing Enterobacteriaceae-related Infection Among Carriers Following Liver Transplantation.
    Transplantation. 2020 Mar 20. doi: 10.1097/TP.0000000000003231.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: